IAIM
VRDN icon

International Assets Investment Management’s Viridian Therapeutics VRDN Stock Holding History

International Assets Investment Management’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77K Hold
150
– – ﹤0.01% 2081
2026
Q1 		$2.87K Sell
150
-200
-57% -$5.94K ﹤0.01% 1930
2025
Q4 		$10.9K Buy
+350
New +$9.6K ﹤0.01% 1637
2024
Q4 		– Sell
-19,997
Closed -$879 – 1929
2024
Q3 		$879 Buy
+19,997
New +$327K ﹤0.01% 1178

Other funds holding VRDN

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM

International Assets Investment Management's VRDN Position: Q2 2026 in Review

International Assets Investment Management held its Viridian Therapeutics (VRDN) position steady in Q2 2026 at 150 shares worth $2.77K. The position accounts for ﹤0.01% of the portfolio, ranked #2081.

International Assets Investment Management first reported a position in VRDN in Q3 2024 and has held it in 4 quarters since. The position peaked at $10.9K in Q4 2025. 28 funds tracked by Wall St. Rank hold VRDN as of Q2 2026.

  • International Assets Investment Management held 150 shares of Viridian Therapeutics worth $2.77K as of Q2 2026.
  • International Assets Investment Management left its Viridian Therapeutics share count unchanged in Q2 2026.
  • Viridian Therapeutics made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #2081 holding.
  • International Assets Investment Management first reported a position in Viridian Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • International Assets Investment Management's Viridian Therapeutics position peaked at $10.9K in Q4 2025.
  • 28 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.